I congressi di renalgate

	DECIMO CORSO EUROPEO DI  AGGIORNAMENTO IL CUORE NELLE NEFROPATIE E NELLA DIALISI Aprile, 1 - 2 - 3, 2004 - Assisi - Italia	TENTH  ASSISI EUROPEAN MEETING ON CARDIONEPHROLOGY    April, 1 - 2 - 3, 2004 - Assisi - Italy

PRESIDENTS

 MARIO TIMIO M.D.                    PERUGIA - ITALY

VOLKER WIZEMANN M.D.       GIESSEN - GERMANY

Second ANNOUNCEMENT

AND CALL FOR ABSTRACTS

PROGRAMMA SCIENTIFICO  - SCIENTIFIC PROGRAM

 

	TENTH ASSISI EUROPEAN MEETING ON CARDIONEPHROLOGY Presidenti - Scientific Presidents: M. TIMIO (Perugia - Italy) V. WIZEMANN (Giessen - Germany) Segreteria Scientifica - Scientific Secretariat: M. TIMIO M.D. - P. SARONIO M.D.- S. VENANZI M.D.- F. TIMIO M.D. - C. VERDURA M.D. Dept. Internal Medicine - Nephrology & Dialysis General Hospital 06034 - Foligno - ITALY Telephone: +39 - 0742 339760 \ 339762 Fax +39 - 0742 339310 E-Mail: timma@libero.it - nefrofo1@asl3.umbria.it Segreteria Organizzativa - Organizing Secretariat: MAVITUR - Via Frate Elia, 2 - 06082 - Assisi - ITALY Telephone: +39 - 075 812377 \ 813083 Fax: +39 - 075 816351 E-Mail: maviturviaggi@tiscalinet.it Sede del Convegno - Meeting Venue AUDITORIUM DELLA "CITTADELLA" 06081 ASSISI - Via Ancajani, 3 Tel. +39 - 075 813231	Invitation to Assisi  Dear Guest,             We are very pleased to welcome You to Assisi on the occasion of the TENTH EUROPEAN MEETING ON CARDIONEPHROLOGY which will be held from Thursday 1st  April to Saturday 3rd April, 2004. All active workers in the cardiovascular field are encouraged to partecipate. It is the wish of the Executive Committee that the 10th Meeting – a special step in the history of Assisi Cardionephrology – will actract both basic scientists and clinicians. The programme will include a number of keynote speakers, oral presentation, workshop and hot topic sessions. Considerable time is set aside for critical discussion, communications and posters.  The conference is thus intended as a forum for critical analysis of the latest advances  and clinical research results in cardiorenal field. As in previous years, a number of grants will be avaiable for young investigators, whose abstracts are accepted for the meeting. Once again, Assisi – the town of real peace - will allow the European delegates to enjoy its beautiful and vivid medioeval atmosphere. We look forward to your active contribution to what we hope will again be an exciting meeting in support of cardionephrology advance.                                             Mario Timio - Volker Wizemann     EXECUTIVE COMMITTEE M. TIMIO M.D. – P. SARONIO M.D. - S. VENANZI M.D. - C. VERDURA M.D. F. TIMIO M.D. -  V. WIZEMANN M.D.  Dept. Internal Medicine - Nephrology & Dialysis - General Hospital 06034 - Foligno - ITALY Telephone:  +39-742  339760 / 339762 - Fax +39-742 339310 E-Mail: timma@libero.it - nefrofo1@asl3.umbria.it
	SCIENTIFIC PROGRAMME   MAIN TOPICS  §          Atherogenesis in nephropathies §          Early cardiovascular derangement in renal patients §        Function of right ventricle in uremia §        Coronary heart disease in uremic patients §        Sport vs angioplasty in coronary heart disease §        Does Mediterranean diet fit to cardiorenal patients? §          Emerging role of oxidative stress: facts and fancies §          Does erytropoietin protect against hypoxic stress? §        Atrial fibrillation in dialysis patients §        Sudden death in dialysis patients §        Acute cardiac failure in renal artery disease §        Different cardiovascular co-morbidity in renal patients in Europe: the study DOPPS and MPO §        Epidemiology of cardiovascular disease in chronic renal failure §        Cardiorenal risk factor in surgery §        Cardiovascular instrumentation in cardiorenal diagnosis §        Total body water in dialysis §        Do convective methods on-line protect cardiovascular system? §        New clinical insight for sartans in cardiorenal protection §        Genetic modulation of organ damage in hypertension §        Control of systolic BP in cardiorenal disease §        Cost-effectiveness of antihypertensive agents: the ALLHAT and ASCOT-LLA studies §        Cardiorenal protection by lipid-lower agents: the NCEP studies §        Cardiorenal protection in diabetes §        The concept of global protection in hypertension ORAL AND POSTER PRESENTATION TO EACH TOPIC EDUCATIONAL SESSION: Controversy in cardiorenal disease; exploration through case discussion. WEB SITE A meeting page is available on the net to the following address: .http:// www.renalgate.it/cardionephrology2004.html Comments and questions to papers available on the web site are welcomed. The most interesting data and questions will be presented by chairmen at the time of the Meeting. ABSTRACTS ON-LINE SUBMISSION Abstracts could be submitted on-line to the following E-mail timma@libero.it or nefrofo1@asl3.umbria.it To submit an abstract the author should access the Assisi Meeting web site at http:// www.renalgate.it/cardionephrology2004.html and click on “Abstract submission” for supplying the instructions. FORMATIVE CREDITS / CREDITI FORMATIVI The Meeting has been submitted for approval for continuing education unit to the Italian Health Minister.	SCIENTIFIC COMMITTEE   E. AGABITI - ROSEI               Brescia                   ITALY M.A. ALPERT                          Mobile                     USA P. ALTIERI                               Cagliari                    ITALY K. AMANN                              Erlangen                 GERMANY G. AMBROSIO                        Perugia                   ITALY V. ANDREUCCI                       Naples                    ITALY G. BELLINGHIERI                    Messina                  ITALY G. BIANCHI                             Milan                       ITALY J.  BLEYER                              Winston Salem        USA M. BOAZ                                Tel Aviv                  ISRAEL M. BRUEKER                           Wetzlar                   GERMANY P. BRUNETTI                           Perugia                   ITALY M. BUEMI                                Messina                  ITALY V. CAMBI                                Parma                     ITALY F.P. CAPPUCCIO                     London                   UK G.A. CINOTTI                          Rome                      ITALY G.N. DE SANTO                      Naples                    ITALY G. DI BONA                            Iowa City                USA H.E. ELIAHOU                         Tel Aviv                  ISRAEL R.N. FOLEY                            St. John’s Newf.     CANADA B. FOLKOW                            Göteborg                SWEDEN M. GUAZZI                             Milano                     ITALY A.G. JARDINE                         Glasgow                 SCOTLAND UK G. LEONETTI                           Milano                     ITALY K.M.L. LEUNISSEN  Maastricht               THE NETHERLANDS F. LOCATELLI                         Lecco                     ITALY G. LONDON                            Paris                       GERMANY A. LOSITO                              Perugia                   ITALY A. MALLIANI                           Milan                       ITALY M. MEOLA                              Pisa                         ITALY G. QUINTALIANI                     Perugia                   ITALY P.S. PARFREY                        St. John’s Newf.       CANADA J.C. ROMERO                         Rochester               USA C. RONCO                              Vicenza                  ITALY A. SANTORO                         Bologna                  ITALY G. SCHILLACI                         Perugia                   ITALY F.P. SCHENA                          Bari                         ITALY G. SPLENDIANI                       Rome                      ITALY J. STAESSEN                         Leuven                   BELGIUM V. TESAR                               Prague                    CHECK REPUBLIC J. TUCKER                              London                   UK P. VERDECCHIA                     Perugia                   ITALY C. WANNER                            Würzburg                               GERMANY R.R. WENZEL                         Essen                     GERMANY V. WIZEMANN                        Giessen                  GERMANY C. ZOCCALI                            Reggio Calabria      ITALY P. ZUCCHELLI                           Bologna                ITALY
	Abstract submission” Abstracts could be submitted on-line to the following E-mail timma@libero.it or nefrofo1@asl3.umbria.it To download the Abstract form click here INFORMAZIONI GENERALI Iscrizione: Prima del 20 febbraio 2004 Partecipanti € 300 Accompagnatori € 100 Dopo il 20 febbraio 2004 Partecipanti € 350 Accompagnatori € 120 La quota partecipanti comprende: ingresso alle sessioni congressuali - kit congressuale e servizio di traduzione simultanea - certificato di iscrizione - buffet di benvenuto - cena di gala - spettacolo musicale - 2 colazioni di lavoro e 3 coffee-break - volume degli Atti - crediti ECM. La quota accompagnatori comprende: buffet di benvenuto - cena di gala - spettacolo musicale - visita guidata di due città umbre e colazione in tipici ristoranti. GENERAL INFORMATION Registration fees: Before February 20, 2004 Delegate € 300 Accompanying person €100 After February 20, 2004 Delegate € 350 Accompanying person € 120 The delegate fee includes: admission to the scientific sessions - congress kit and simultaneous translation facilities -attendance certificate - opening reception - gala banquet - musical entertainment - 2 lunches and 3 coffee-breaks - proceedings volume - CME credits. The accompanying person fee includes: opening reception -gala banquet - musical entertainment - excursion to two umbria towns and lunches on route. ESPOSIZIONE TECNICO-FARMACEUTICA TECHNICAL-SCIENTIFIC EXHIBITION Un'esposizione tecnico farmaceutica sara' allestita nell'area del Convegno per tutta la durata dei lavori. A section of the congress area will house the technical-scientific exhibition during the meeting.	ORGANIZING SECRETARIAT MAVITUR - via Frate Elia, 2 - 06082 - Assisi - ITALY Telephone: +39-75 812377 / 813083 - Fax +39-75 816351 E-Mail: maviturviaggi @tiscalinet.it   MEETING VENUE Auditorium Cittadella - Via Ancaiani, 3 Assisi. Tel +39-75 813231 INFORMAZIONI SCIENTIFICHE Coloro che intendono presentare comunicazioni sono pregati di inviare l'accluso Abstract Form entro il 10 Gennaio 2004 . Al primo autore dei lavori accettati saranno inviati i forms con le relative istruzioni per la stesura definitiva del testo che dovra' pervenire entro il 20 Febbraio 2004 alla Segreteria Scientifica per poter essere inserito nel volume degli Atti pubblicato per la data del convegno. SCIENTIFIC INFORMATION Those who intend to present papers are kindly invited to submit the Abstract Form by January 10, 2004. The first author of selected abstracts will be sent forms with relative instructions regarding the final draft of the text, which should arrive at the Scientific Secretariat no later than February 20, 2004, in order to be included in the Proceeding Volume published for the convention. PREMIO "ASSISI MEDICINA" Nel corso del Convegno sara' conferito il Premio "Assisi Medicina" (€ 3000) ai migliori lavori scientifici inediti presentati come comunicazione o poster da giovani ricercatori (eta' inferiore a 40 anni alla data del 1 Gennaio 2004). "ASSISI MEDICINA" AWARD The "Assisi Medicina" award (€ 3000) will be conferred to the best unpublished scientific works presented in oral or poster form, to young researchers aged 40 years or under by the 1st January 2004.

	PROGRAMMA SCIENTIFICO  - SCIENTIFIC PROGRAM 1a SESSIONE - 1st SESSION FATTORI EMERGENTI NELLA PATOLOGIA CARDIOVASCOLARE DELL'UREMICO - EMERGING FACTORS IN UREMIC CARDIOVASCULAR DISEASE Patologia arteriosa nell'insufficienza renale - Arteries in renal failure - Componenti immunologici dell'aterosclerosi - Immunological components of atherosclerosis - Anticorpi anti-fosfolipidi nella patologia cardiorenale: nuove acquisizioni - Antiphospholipid antibodies in cardiorenal disease: new insight - Ruolo dell'ADMA nella patologia cardiorenale - ADMA role in cardiorenal disease - Ruolo emergente dello stress ossidativo: fantasia o realtà? - Emerging role of oxidative stress: fact or fiction? K. AMANN (Erlagen - Germany); V. ANDREUCCI (Naples - Italy; M. BOAZ (Tel-Aviv - Israel); P. SCHENA (Bari - Italy); G. SPLENDIANI (Rome - Italy); V. TESAR (Prague - Czech Republic); C. WANNER (Würzburg - Germany); C. ZOCCALI (Reggio C. - Italy). 2a SESSIONE - 2nd SESSION CLINICA DELLA MALATTIA CARDIACA NELL'UREMICO - CLINIC OF CARDIAC DISEASE IN UREMIC PATIENTS Precoci alterazioni cardiovascolari nell'insufficienza renale - Early cardiovascular derangement in renal patients - Malattia nefrovascolare e insufficienza cardiaca - Cardiac failure in renal artery disease - Funzione ventricolare destra nell'uremia - Right ventricle function in uremia - Fibrillazione atriale nell'uremia - Atrial fibrillation in uremia - Morte cardiaca nel paziente dializzato - Cardiac death in dialysis patient. E. BRUECK (Wetzlhar - Germany); G. CANNELLA (-); A. LOSITO (Perugia - Italy); M. TIMIO (Perugia - Italy); V. WIZEMANN (Giessen - Germany). 3a SESSIONE - 3rd SESSION STRUMENTAZIONE CARDIOVASCOLARE NELLA PATOLOGIA CARDIORENALE - CARDIOVASCULAR INSTRUMENTATION IN CARDIORENAL DISEASE Nuovi strumenti diagnostici - New diagnostic tools - Ruolo dell'ecografia nella pratica cardionefrologica giornaliera - Echography role in daily cardionephrology - Diagnostica delle calcificazioni vascolari nll'insufficienza renale: strumentazione emergente - Assessment of vascular calcification in ESRD patients: emerging instrumentation. L'emofiltrazione nella nefropatia da mezzi di contrasto - Haenofiltration in the radio-contrast-agent-induced nephropathy M.A. ALPERT (Mobile - U.S.A.);D. Brancaccio (Milan - Italy); G. Marenzi (Milan - Italy); M. MEOLA (Pisa - Italy); S.M. MOE (Indianapolis - USA).
	4a SESSIONE - 4th SESSION APPARATO CARDIOVASCOLARE NEL PAZIENTE DIALIZZATO - CARDIOVASCULAR SYSTEM IN DIALYSIS PATIENTS Epidemiologia della malattia cardiovascolare in dialisi - Epidemiology of cardiovascular disease in dialysis - Diversa co-morbidità cardiovascolare nei pazienti nefropatici in Europa: gli studi DOPS e MPO - Different cardiovascular co-morbidity in renal patients in Europe: the study DOPS and MPO - Acqua corporea totale nel dializzato - Total body water in dialysis - Metodi convettivi on-line e protezione cardiovascolare - Do convective methods on-line protect cardiovascular system? - Rischio cardiovascolare in chirurgia - Cardiorenal risk factor in surgery V. CAMBI (Parma - Italy); B. CHARRA (Tassin - Belgium); K.M.L LEUNISSEN (Maastricht - The Netherlands); F. LOCATELLI (Lecco - Italy); P.S. PARFREY (St. John's Newfoundland - Canada); G. PONTORIERO (Lecco - Italy); T. RAGNI (Perugia - Italy); A. SANTORO (Bologna - Italy). 5a SESSIONE - 5th SESSION IPERTENSIONE E NEFROPATIA - HYPERTENSION AND RENAL DISEASE Modulazione genetica del danno d'organo nell'ipertensione - Genetic modulation of organ damage in hypertension - Ruolo della pressione sistolica nel danno d'organo: nuove acquisizioni - The role of systolic blood pressure in target organ damage: new insight - Importanza del precoce controllo pressorio sulle complicanze cardiorenali - The importance of early blood pressure control in cardiorenal consequences - Ipertensione come causa o effetto delle alterazioni arteriose nell'uremia? -Impairment of arterial dysfunction in uremic patients: cause or effect of hypertension? G. BIANCHI (Milan - Italy); G. CINOTTI (Rome - Italy); G. LONDON (Paris - France); G. PONTREMOLI (Genoa - Italy); G. SPLENDIANI (Rome - Italy); J. STAESSEN (Leuven - Belgium); P. VERDECCHIA (Perugia - Italy). 6a SESSIONE - 6th SESSION TERAPIE CARDIOVASCOLARI NEL PAZIENTE UREMICO - CARDIOVASCULAR THERAPIES IN UREMIC PATIENTS La dieta mediterranea è adatta al paziente nefropatico con malattia coronarica? - Does Mediterranean diet fit to renal patients with coronary artery disease? - Nuove acquisizioni cliniche sulla protezione cardiorenale dei sartani - New clinical insight into sartans cardiorenal protection - Controversie sul rapporto costo-beneficio della terapia antiipertensiva: grandi trial - Controversies from large interventional trials on cost-effectiveness of antihypertensive therapy - L'eritropoietina protegge dallo stress ipossico? - Does erythropoietin protect against hypoxic stress? - Protezione cardiorenale nel diabetico - Cardiorenal protection in diabetes. E.M. BERRY (Jerusalem - Israel); P. BRUNETTI (Perugia - Italy); M. BUEMI (Messina - Italy); - A.G. JARDINE (Glasgow - Scotland U.K.); G. SCHILLACI (Perugia - Italy). COMUNICAZIONI E PRESENTAZIONE DI POSTER COMMUNICATIONS AND POSTER PRESENTATION EDUCATIONAL SESSION Controversie in patologia cardiorenale; presentazione di casi - Controversy in cardiorenal disease; exploration through case discussion. V. CAMBI (Parma - Italy); V. ELIAHOU (Tel-Aviv - Israel); R. NAMI (Siena - Italy); I. RICHLIK (Prague - Czech Republic); T. ZIMA (Prague - Czech Republic).